THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)

被引：329

作者：

CHEN, RT ^{[1
]}

RASTOGI, SC ^{[1
]}

MULLEN, JR ^{[1
]}

HAYES, SW ^{[1
]}

COCHI, SL ^{[1
]}

DONLON, JA ^{[1
]}

WASSILAK, SG ^{[1
]}

机构：

[1] US FDA,CTR BIOL EVALUAT & RES,ROCKVILLE,MD 20857

来源：

VACCINE | 1994年 / 12卷 / 06期

关键词：

VACCINATION; IMMUNIZATION; ADVERSE REACTIONS; PRODUCT SURVEILLANCE; POSTMARKETING;

D O I：

10.1016/0264-410X(94)90315-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunizations against most vaccine-preventable diseases will be needed indefinitely unless the disease is eradicated. Public acceptance of immunizations may be threatened as vaccine coverage increases and disease decreases, however, due to the increase in both causally and coincidentally related vaccine adverse events. The post-marketing surveillance for such events in the USA in response to the mandatory reporting requirements of the National Childhood Injury Act of 1986. While VAERS has many methodological limitations intrinsic to such systems, it can play an important role in helping to monitor vaccine safety and maintain public confidence in immunizations.

引用

下载

页码：542 / 550

页数：9

共 50 条

[31] COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Bing Zhang
Xiao Yu
Jinxing Liu
Jinbao Liu
Pengfei Liu
BMC Women's Health, 22
[32] Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017
Suragh, Tiffany A.
Lewis, Paige
Arana, Jorge
Mba-Jonas, Adamma
Li, Rongxia
Stewart, Brock
Shimabukuro, Tom T.
Cano, Maria
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (12) : 2928 - 2932
[33] COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Zhang, Bing
Yu, Xiao
Liu, Jinxing
Liu, Jinbao
Liu, Pengfei
BMC WOMENS HEALTH, 2022, 22 (01)
[34] Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning
Du, Jingcheng
Xiang, Yang
Sankaranarayanapillai, Madhuri
Zhang, Meng
Wang, Jingqi
Si, Yuqi
Pham, Huy Anh
Xu, Hua
Chen, Yong
Tao, Cui
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 28 (07) : 1393 - 1400
[35] Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013
Sukumaran, Lakshmi
McNeil, Michael M.
Moro, Pedro L.
Lewis, Paige W.
Winiecki, Scott K.
Shimabukuro, Tom T.
CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) : E58 - E65
[36] Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013
Hibbs, Beth F.
Moro, Pedro L.
Lewis, Paige
Miller, Elaine R.
Shimabukuro, Tom T.
VACCINE, 2015, 33 (28) : 3171 - 3178
[37] Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database
Geier, David A.
Geier, Mark R.
IMMUNOLOGIC RESEARCH, 2017, 65 (01) : 46 - 54
[38] Descriptive epidemiology of adverse events after immunization: Reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994
Braun, MM
Ellenberg, SS
JOURNAL OF PEDIATRICS, 1997, 131 (04): : 529 - 535
[39] Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS)
Wodi, Patricia
Marquez, Paige
Mba-Jonas, Adamma
Barash, Faith
Nguon, Kosal
Moro, Pedro L.
VACCINE, 2023, 41 (09) : 1616 - 1622
[40] Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS)
DiMiceli, L
Pool, V
Kelso, JM
Shadomy, SV
Iskander, J
VACCINE, 2006, 24 (06) : 703 - 707

← 1 2 3 4 5 →